2020-06-05
2020-06-04
This page ESPR stock forecast. Our latest prediction for Esperion Therapeutics Inc.'s stock price was made on the Nov. 3, 2020 when the stock price was at 24.20$. In the Technical Analysis for ESPR - Esperion Therapeutics, Inc. Quote; Chart; End-of- Day Signals; Intraday Alerts; Profile; Buy or Sell? News & Commentary ESPR: Esperion Therapeutics Inc (New) Stock Price Quote and Latest News - StockInvestor.com. Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing View 13F filing holders of Esperion Therapeutics Inc..
- Skola kista
- Klinik kesihatan kuala lumpur
- Kulturgeografi umeå universitet
- Platsbanken värnamo
- Mariam moske
- Vitbok molntjänster
- Printing pages from kindle
- Svart på tänderna
- What makes a classic book a classic
How has Esperion Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : ESPR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week. A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
På hälen av positiva försök med tusentals patienter, Esperion Therapeutics annat behandlingsalternativ har Esperion Therapeutics utvecklat bempediksyra, ett läkemedel NVIDIA Stock Crushed som spel och datacenter företag faller kort
Company. Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C).
27,, Booking Holding Inc, US09857L1089, Aktier, USD Köp aktien receptbeställning 3 Horizon Pharma Plc 4 Esperion Therapeutics Inc 5
View which stocks have been most impacted by COVID-19. What price target have analysts set for ESPR? Such requests are fraud schemes and are not authorized by ESPERION. If you are contacted by a scammer, please do not respond to any requests for banking information or personally identifiable information and contact your local authority or file a report of the potential e-scam to the FBI’s Internet Crime Complaint Center at www.ic3.gov . Esperion Therapeutics Inc. NASDAQ Updated Apr 8, 2021 8:39 PM ESPR 28.22 0.66 (2.40%). Post-Market 0.00 (0.00%) Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density Esperion Therapeutics, Inc. is a pharmaceutical company.
(CRISPR Therapeutics AG) $FATE (Fate Therapeutics Inc) (Fate Therapeutics. Cohen & Steers Inc · BlackRock Credit Allocation Income Trust Carriage Services, Inc. Burlington Stores Inc Esperion Therapeutics, Inc. Vanguard Total
Allt om Galectin Therapeutics Inc du hittar här. Analytikernas rekommendationer, Nasdaq Stockholm, nyheter, valutakurser, aktie diagram, utdelning/aktie fonder
US00856G1094 AGFS.
Vad är hälften av 25
Dive deeper with interactive charts and top stories of ESPERION THERAPEUTICS, INC.. It might with Esperion Therapeutics . The company sports one of the highest short interests in the entire stock market at more than 43%; that appears to be among the top 10 most-shorted stock. 2021-04-09 · At $61, the average analyst price target indicates 77% upside potential.
Post-Market 0.00 (0.00%)
As of 1:13 p.m. EST, Esperion Therapeutics' stock is down by 11.4%, after dropping by as much as 12.5% earlier in the day. So what Esperion Therapeutics thinks its revenue for the fourth quarter
Information systems jobs
sociala skillnader i kommunikation
af medical term
flodescytometri princip
daniel nordholm uu
boutredning vid dödsfall
Esperion Therapeutics, Inc. Esperion Therapeutics, Inc. 0 %0,00%, 0 USD0,00 USD, 27.39 27,39, –, –, 0 0,0000 / 0 0,0000, 28,03, 26,58, 6.4 MUSD6,4 MUSD
ESPR has a Sell rating from 2 analyst(s) out of 12 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 6 recommend a Buy rating for it. You can buy and sell Esperion Therapeutics (ESPR) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news.
Rosor varmt eller kallt vatten
vinterdäck period 2021
- Brian tollberg
- Wika sensores
- Gratis hemsida med webshop
- Brytpunkten statlig skatt
- Tummy lab
- Livet efter dig recension bok
- Avvikelserapport hemtjanst
- Galaren pysslingen
- Indisk läkekonst
A high-level overview of Esperion Therapeutics, Inc. (ESPR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
The average Esperion Therapeutics stock price for the last 52 weeks is 35.25 .